Clinical Trial: A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07103018) titled 'A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)' on July 21.

Brief Summary: Study K36-MCRPC-001 is the first in human clinical trial testing KTX-2001 alone and with darolutamide in men with metastatic castration-resistant prostate cancer. The study aims to assess whether the drug is safe, increasing doses alone and in combination with darolutamide, whether it is effective in treating metastatic castration-resistant prostate cancer, and measuring how the drug(s) behaves in the body.

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: Metastatic Castration-r...